Hepatobiliary Surgery Practice Questions

Q: A 60-year-old woman, recovering from major pelvic cancer surgery, develops severe abdominal pain and sepsis. Following a positive HIDA scan, laparotomy is performed. The gallbladder is found to be severely inflamed and removed. There is no evidence of gallbladder stones. Which of the following is true regarding acalculous cholecystitis?

Its frequency is increased after trauma or operation.. **Explanation:** **Acalculous cholecystitis** is an acute inflammation of the gallbladder in the absence of gallstones. It typically occurs in critically ill patients, such as those recovering from major non-biliary surgery (like the pelvic surgery in this case), severe trauma, extensive burns, or prolonged parenteral nutrition. **1. Why Option D is Correct:** The pathogenesis involves a combination of **bile stasis** (due to fasting and lack of CCK-mediated gallbladder contraction) and **gallbladder ischemia** (due to hypotension, dehydration, or sepsis). These factors lead to mucosal injury and secondary infection. Post-operative and post-traumatic states are classic triggers for this condition. **2. Why Other Options are Incorrect:** * **Option A:** By definition, acalculous cholecystitis occurs **without stones** in the gallbladder or the common bile duct. * **Option B:** It is relatively rare, accounting for only **5–10%** of all cases of acute cholecystitis, not 10-20%. * **Option C:** It has a **worse prognosis** than calculous cholecystitis. Because it occurs in already debilitated patients and has a higher risk of gangrene (50%) and perforation (10%), the mortality rate is significantly higher (up to 30%). **Clinical Pearls for NEET-PG:** * **Diagnosis:** Ultrasound is the initial test, but a **HIDA scan** (showing non-visualization of the gallbladder) is the most sensitive confirmatory test. * **Risk Factors:** Major surgery, burns, sepsis, multi-organ failure, and prolonged TPN. * **Management:** Cholecystectomy is definitive; however, in unstable patients, **percutaneous cholecystostomy** is the preferred initial stabilizing procedure.

Q: Which of the following tumors is typically found incidentally during investigations?

Hemangioma. **Explanation:** **Cavernous Hemangioma** is the most common benign tumor of the liver. It is typically a small, solitary lesion composed of blood-filled endothelial-lined spaces. The vast majority of hemangiomas are asymptomatic and do not undergo malignant transformation; therefore, they are most frequently discovered **incidentally** during abdominal imaging (USG or CT) performed for unrelated reasons. **Analysis of Options:** * **Adenoma (Option B):** While some are incidental, Hepatic Adenomas are clinically significant because they carry a risk of spontaneous rupture (causing intraperitoneal hemorrhage) and malignant transformation into Hepatocellular Carcinoma (HCC). They are strongly associated with oral contraceptive use. * **Hamartoma (Option C):** Mesenchymal hamartomas are rare benign tumors primarily seen in infants and young children. They often present as a rapidly enlarging abdominal mass rather than an incidental finding in adults. * **Lymphoma (Option D):** Primary hepatic lymphoma is extremely rare. Secondary involvement usually presents with systemic symptoms (B-symptoms), hepatomegaly, or abnormal liver function tests, making it unlikely to be a purely incidental finding. **High-Yield Clinical Pearls for NEET-PG:** * **Imaging Gold Standard:** Triple-phase CT shows **peripheral globular enhancement** with "centripetal filling" (delayed opacification toward the center). * **Management:** Most require no treatment. Surgery (enucleation or resection) is reserved only for very large ("Giant" >10cm) symptomatic lesions or those with a risk of rupture. * **Contraindication:** Percutaneous biopsy is generally avoided due to the high risk of hemorrhage. * **Kasabach-Merritt Syndrome:** A rare complication where a giant hemangioma causes consumptive coagulopathy and thrombocytopenia.

Q: Which of the following is not a major high-risk factor for cholangiocarcinoma?

Choledocholithiasis. **Explanation:** The development of cholangiocarcinoma (CCA) is strongly associated with conditions causing **chronic biliary inflammation and stasis**. **Why Choledocholithiasis is the correct answer:** While **Choledocholithiasis** (stones in the common bile duct) causes inflammation, it is generally **not** considered a major high-risk factor for cholangiocarcinoma. In contrast, **Hepatolithiasis** (intrahepatic stones) is a well-established major risk factor due to the prolonged, recurrent pyogenic cholangitis and mucosal dysplasia it induces. Simple ductal stones are common and rarely progress to malignancy compared to the other listed conditions. **Analysis of Incorrect Options:** * **Chronic Typhoid (A):** Chronic carriers of *Salmonella typhi* (especially those with gallbladder colonization) have a significantly increased risk of biliary tract cancers due to chronic bacterial irritation and the production of carcinogenic metabolites. * **C. sinensis infestation (C):** Liver flukes (*Clonorchis sinensis* and *Opisthorchis viverrini*) are Group 1 carcinogens. They cause chronic mechanical injury and inflammation of the bile duct epithelium, making them a leading cause of CCA in endemic regions (Southeast Asia). * **Ulcerative Colitis (D):** This is strongly associated with **Primary Sclerosing Cholangitis (PSC)**. PSC is the most common predisposing factor for cholangiocarcinoma in Western countries, with a lifetime risk of 10-15%. **High-Yield Facts for NEET-PG:** * **Most common site:** Perihilar (Klatskin tumor) is the most common location for CCA. * **Tumor Marker:** **CA 19-9** is the most commonly used marker for diagnosis and monitoring. * **Choledochal Cysts:** Type I and Type IV cysts carry the highest risk of malignant transformation. * **Risk Factor Mnemonic:** Remember the "S's": **S**tones (Intrahepatic), **S**clerosing Cholangitis, **S**almonella, and **S**pirit (Alcohol/Cirrhosis).

Q: Which of the following is the most common complication of this procedure?

Metabolic encephalopathy. ***Metabolic encephalopathy*** - **Hepatic encephalopathy** occurs in **25-35%** of patients post-TIPS due to bypassing hepatic metabolism of **nitrogenous compounds** like ammonia. - The shunt creates a direct connection between portal and systemic circulation, reducing the liver's ability to **detoxify** blood from the GI tract. *Shunt stenosis* - While **shunt stenosis** can occur, it is typically a **delayed complication** that develops over months to years, not the most common immediate issue. - Modern **covered stent grafts** have significantly reduced the incidence of stenosis compared to bare metal stents. *Capsular hemorrhage* - **Hepatic capsular hemorrhage** is a rare procedural complication occurring in less than **2-5%** of cases during needle puncture. - It is typically **self-limiting** and managed conservatively with observation and supportive care. *Recurrent variceal bleed* - **Recurrent bleeding** can occur if the shunt becomes **stenotic** or **occluded**, but this is a secondary complication rather than primary. - TIPS is specifically designed to **reduce portal pressure** and prevent variceal rebleeding, making this less common than encephalopathy.

Q: Increased risk of hepatic malignancy is seen in which benign liver tumor?

Hepatic adenoma. **Explanation:** **Hepatic Adenoma (HA)** is a benign epithelial liver tumor primarily seen in young women using oral contraceptives. It is the correct answer because it carries a significant risk of **malignant transformation into Hepatocellular Carcinoma (HCC)** (approximately 5–10%) and a high risk of spontaneous rupture leading to intraperitoneal hemorrhage. The risk of malignancy is particularly high in the **β-catenin mutated subtype** and in male patients. Due to these risks, surgical resection is often recommended for adenomas >5 cm or those occurring in men. **Why other options are incorrect:** * **Hemangioma:** This is the most common benign liver tumor. It consists of blood-filled vascular spaces and has **zero malignant potential**. Management is usually conservative unless the patient is symptomatic. * **Focal Nodular Hyperplasia (FNH):** This is a regenerative response to a vascular malformation (characterized by a "central stellate scar"). It is considered a "leave-alone" lesion because it has **no risk of malignancy** or rupture. * **Hemangioendothelioma:** While epithelioid hemangioendothelioma is a rare vascular tumor with "intermediate" or low-grade malignant potential, it is not classified as a standard benign tumor that transforms into HCC in the context of this classic surgical comparison. **High-Yield Clinical Pearls for NEET-PG:** * **Most common benign liver tumor:** Hemangioma. * **Tumor associated with OCPs:** Hepatic Adenoma. * **Central Stellate Scar:** Pathognomonic for FNH (seen on CT/MRI). * **Hot uptake on Sulfur Colloid Scan:** FNH (due to presence of Kupffer cells); Adenomas appear "cold." * **Management Rule:** Asymptomatic Hemangiomas and FNH are managed conservatively; Adenomas >5cm require surgery due to rupture/malignancy risk.

Q: What incision approach is used for a mesocaval shunt?

Midline. **Explanation:** The **mesocaval shunt** is a portosystemic shunt performed to decompress portal hypertension by connecting the superior mesenteric vein (SMV) to the inferior vena cava (IVC), often using a synthetic H-graft. **Why Midline is correct:** The procedure requires extensive exposure of the retroperitoneum and the root of the mesentery. A **long midline incision** (from xiphoid to below the umbilicus) provides the best vertical access to both the SMV (located in the mesentery) and the infrarenal IVC (located retroperitoneally). It allows the surgeon to mobilize the transverse colon superiorly and the small bowel to the right to reach the vascular structures efficiently. **Why other options are incorrect:** * **Paramedian:** This incision is rarely used in modern vascular or hepatobiliary surgery as it is time-consuming to perform and offers no significant exposure advantage over the midline approach. * **Subcostal (Kocher’s):** While excellent for gallbladder or biliary tree surgery, a unilateral subcostal incision does not provide enough inferior exposure to reach the infrarenal IVC. * **Chevron (Bilateral Subcostal):** This is the gold standard for liver transplants and major hepatic resections. However, for a mesocaval shunt, the pathology is deeper in the mid-abdomen/retroperitoneum rather than the upper quadrants, making the midline incision more direct and less morbid. **High-Yield Clinical Pearls for NEET-PG:** * **Portocaval Shunt:** Usually performed via a **Right Subcostal** or **Chevron** incision (due to the high location of the portal vein). * **Distal Splenorenal Shunt (Warren Shunt):** Typically performed via a **Left Subcostal** or Midline incision. * **Indication:** Mesocaval shunts are often preferred in patients with previous upper abdominal surgery or those with a small diameter splenic vein.

Q: All of the following are known predisposing factors for cholangiocarcinoma except:

CBD stones. **Explanation:** The correct answer is **A. CBD stones**. While chronic irritation is a hallmark of cholangiocarcinoma (CCA) pathogenesis, simple Common Bile Duct (CBD) stones (choledocholithiasis) are generally not considered a direct independent risk factor for the development of CCA. In contrast, **intrahepatic stones (hepatolithiasis)** are strongly associated with the disease due to chronic recurrent pyogenic cholangitis. **Analysis of Options:** * **Clonorchis sinensis:** This liver fluke (along with *Opisthorchis viverrini*) is a classic risk factor. Chronic infection leads to biliary inflammation, hyperplasia, and eventual malignant transformation. * **Ulcerative Colitis (UC):** UC is indirectly linked via its strong association with Primary Sclerosing Cholangitis (PSC). Patients with UC have a significantly higher lifetime risk of developing CCA compared to the general population. * **Primary Sclerosing Cholangitis (PSC):** This is the most common predisposing factor for CCA in the Western world. About 10-15% of PSC patients will develop cholangiocarcinoma. **NEET-PG High-Yield Pearls:** * **Choledochal Cysts:** Type I and Type IV cysts carry the highest risk of malignancy; surgical excision is mandatory. * **Thorotrast:** A historical radiologic contrast agent strongly linked to CCA and Angiosarcoma of the liver. * **Tumor Marker:** **CA 19-9** is the most commonly used marker for monitoring, though it can be elevated in benign obstructive jaundice. * **Anatomy:** The most common site for CCA is the confluence of the hepatic ducts (**Klatskin Tumor**).

Q: Splenectomy is useful in:

Hereditary Spherocytosis. **Explanation:** **Hereditary Spherocytosis (HS)** is the correct answer because it is the most common indication for elective splenectomy in children. In HS, a defect in red blood cell (RBC) membrane proteins (like spectrin or ankyrin) leads to the formation of spherical, rigid cells. These spherocytes are trapped and destroyed by the splenic macrophages in the cords of Billroth. Splenectomy does not cure the membrane defect, but it significantly increases RBC lifespan, eliminates chronic hemolysis, and prevents the formation of pigment gallstones. **Why other options are incorrect:** * **Hemophilia:** This is a clotting factor deficiency (Factor VIII or IX). Splenectomy has no role in management as it does not affect factor levels. * **Polycythemia:** This involves an overproduction of RBCs. Management focuses on phlebotomy or myelosuppressive agents. Splenectomy is generally avoided as it may worsen the thrombotic risk already present in these patients. * **Thalassemia:** While splenectomy is sometimes performed in Thalassemia Major to reduce transfusion requirements (if hypersplenism develops), it is not the primary treatment and is less "curative" for the symptoms compared to its role in HS. **NEET-PG High-Yield Pearls:** * **Timing:** In HS, splenectomy is ideally delayed until after age 5 to reduce the risk of **OPSI** (Overwhelming Post-Splenectomy Infection). * **Prophylaxis:** Patients must receive vaccinations against *S. pneumoniae, H. influenzae,* and *N. meningitidis* at least 2 weeks before elective surgery. * **Post-op Blood Picture:** Look for **Howell-Jolly bodies**, Pappenheimer bodies, and Heinz bodies on a peripheral smear post-splenectomy. * **Associated Procedure:** Always screen for gallstones (cholelithiasis) in HS patients; if present, a concomitant cholecystectomy is performed.

Q: Which of the following types of hydatid cyst denotes a complicated cyst?

Type IV. The classification of hydatid cysts is primarily based on the **Gharbi Classification** (ultrasound-based), which is crucial for determining management strategies. ### **Explanation of the Correct Answer** **Type IV** cysts are characterized as **solid or heterogenous masses** with no visible internal vesicles. This appearance represents a "pseudotumor" pattern. In the context of the Gharbi classification, Types I, II, and III are considered "active" or "simple" stages of the parasite's life cycle. **Type IV and Type V** are considered **complicated or inactive/degenerate** stages. Specifically, Type IV indicates that the parasite is dying or that the cyst has undergone internal degeneration, making it a "complicated" presentation compared to the clear, fluid-filled active stages. ### **Analysis of Incorrect Options** * **Type I (Option A):** Purely fluid-filled, unilocular collection. It is an **active** cyst (simple). * **Type II (Option B):** Characterized by fluid collection with a "split wall" (detached endocyst) or "water lily sign." It is an **active** cyst. * **Type III (Option C):** Multivesicular cyst with a "honeycomb" appearance due to daughter cysts. It is an **active/transitional** cyst. ### **NEET-PG High-Yield Pearls** * **Gharbi Classification Summary:** * **Type I:** Pure fluid (Active) * **Type II:** Detached membranes (Active) * **Type III:** Daughter cysts/Honeycomb (Active) * **Type IV:** Heterogenous/Solid (Degenerative/Complicated) * **Type V:** Calcified wall (Inactive/Dead) * **Treatment Choice:** Active cysts (I-III) often require PAIR (Puncture, Aspiration, Injection, Re-aspiration) or surgery, whereas Type IV and V are often managed with "watch and wait" unless symptomatic. * **Drug of Choice:** Albendazole (10-15 mg/kg/day) is the mainstay of medical therapy.

Question 1

A 60-year-old woman, recovering from major pelvic cancer surgery, develops severe abdominal pain and sepsis. Following a positive HIDA scan, laparotomy is performed. The gallbladder is found to be severely inflamed and removed. There is no evidence of gallbladder stones. Which of the following is true regarding acalculous cholecystitis?

Accepted Answer

Its frequency is increased after trauma or operation.

Answer

It is usually associated with stones in the common bile duct.

Answer

It occurs in 10-20% of all cases of cholecystitis.

Answer

It has a more favorable prognosis than calculous cholecystitis.

Question 2

Which of the following tumors is typically found incidentally during investigations?

Accepted Answer

Hemangioma

Answer

Adenoma

Answer

Hamartoma

Answer

Lymphoma

Question 3

Which of the following is not a major high-risk factor for cholangiocarcinoma?

Accepted Answer

Choledocholithiasis

Answer

Chronic typhoid

Answer

C. sinensis infestation

Answer

Ulcerative colitis

Question 4

Which of the following is the most common complication of this procedure?

Accepted Answer

Metabolic encephalopathy

Answer

Shunt stenosis

Answer

Capsular hemorrhage

Answer

Recurrent variceal bleed

Question 5

Increased risk of hepatic malignancy is seen in which benign liver tumor?

Accepted Answer

Hepatic adenoma

Answer

Hemangioma

Answer

Focal nodular hyperplasia

Answer

Hemangioendothelioma

Question 6

What incision approach is used for a mesocaval shunt?

Accepted Answer

Midline

Answer

Paramedian

Answer

Subcostal

Answer

Chevron

Question 7

Which of the following originates at the hilum of the liver?

Accepted Answer

Klatskin tumor

Answer

Cholangiocarcinoma

Answer

Caroli disease

Answer

Primary sclerosing cholangitis

Question 8

All of the following are known predisposing factors for cholangiocarcinoma except:

Accepted Answer

CBD stones

Answer

Clonorchis sinensis

Answer

Ulcerative colitis

Answer

Primary sclerosing cholangitis

Question 9

Splenectomy is useful in:

Accepted Answer

Hereditary Spherocytosis

Answer

Hemophilia

Answer

Polycythemia

Answer

Thalassemia

Question 10

Which of the following types of hydatid cyst denotes a complicated cyst?

Accepted Answer

Type IV

Answer

Type I

Answer

Type II

Answer

Type III

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?